119 related articles for article (PubMed ID: 30431107)
1. MicroRNA‑584 directly targets CCND1 and inhibits cell proliferation and invasion in pancreatic cancer.
Chen G; Hu M; Qu X; Wang K; Qu Y
Mol Med Rep; 2019 Jan; 19(1):719-726. PubMed ID: 30431107
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑584 prohibits hepatocellular carcinoma cell proliferation and invasion by directly targeting BDNF.
Song Y; Wang G; Zhuang J; Ni J; Zhang S; Ye Y; Xia W
Mol Med Rep; 2019 Aug; 20(2):1994-2001. PubMed ID: 31257521
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑720 inhibits pancreatic cancer cell proliferation and invasion by directly targeting cyclin D1.
Zhang Y; Su Y; Zhao Y; Lv G; Luo Y
Mol Med Rep; 2017 Dec; 16(6):9256-9262. PubMed ID: 28990111
[TBL] [Abstract][Full Text] [Related]
4. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
Zhang L; Sun D; Zhang J; Tian Y
Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
[TBL] [Abstract][Full Text] [Related]
5. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 regulates Gli3 expression and inhibits pancreatic cancer cells growth and migration.
Ma Y; Li G; Hu J; Liu X; Shi B
J Cell Biochem; 2018 Jul; 119(7):5324-5331. PubMed ID: 29315756
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
Chang W; Wang Y; Li W; Shi L; Geng Z
J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
[TBL] [Abstract][Full Text] [Related]
8. miR‑448 targets Rab2B and is pivotal in the suppression of pancreatic cancer.
Jin J; Wu Y; Zhou D; Sun Q; Wang W
Oncol Rep; 2018 Sep; 40(3):1379-1389. PubMed ID: 30015954
[TBL] [Abstract][Full Text] [Related]
9. Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1.
Zhao W; Hu JX; Hao RM; Zhang Q; Guo JQ; Li YJ; Xie N; Liu LY; Wang PY; Zhang C; Xie SY
Oncol Rep; 2018 Oct; 40(4):1843-1854. PubMed ID: 30066899
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma.
Radulovich N; Pham NA; Strumpf D; Leung L; Xie W; Jurisica I; Tsao MS
Mol Cancer; 2010 Feb; 9():24. PubMed ID: 20113529
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
13. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
[TBL] [Abstract][Full Text] [Related]
18. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
[TBL] [Abstract][Full Text] [Related]
19. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
